ArticleTranslational cancer research2022
Classification of contrast-enhanced ultrasonograms in rectal cancer according to tumor inhomogeneity using machine learning-based texture analysis.
Article in Translational cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prediction of regional lymph node metastasis in rectal cancer: a novel model based on transrectal contrast-enhanced ultrasound.Discover oncology · 2025Article
- Combined transrectal ultrasound and radiomics model for evaluating the therapeutic effects of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.International journal of colorectal disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inhomogeneity within tumors can reflect tumor angiogenesis. Existing research into the quantization of angiogenesis mainly focuses on time-intensity curve parameters but has produced inconsistent results. In clinical work, it is difficult to achieve standardization and consistency for manual judgement of the inhomogeneity of contrast-enhanced images, while the artificial intelligence technology may be helpful. The aim of this study was to assess whether computers can assist in the artificial classification of tumor inhomogeneity in contrast-enhanced ultrasound (CEUS) images of rectal cancer. Methods: A total of 500 contrast-enhanced ultrasonograms were retrospectively collected, which was verified of rectal cancer pathologically from 2016 to 2018 as training set. All images are from 18-80 years old patients with rectal cancer in our hospital. These tumors are usually located in the middle and lower segment of the rectum, which can be completely observed on ultrasound. The images were divided into 3 categories according to the inhomogeneous distribution of contrast agents inside the tumors. Computing methods were used to simulate manual classification. Computer processing steps included segmentation, gray level quantization, dimension reduction, and classification. The results of 6 different gray level quantization, 2 dimensionality reduction methods, and 3 classifiers were compared, from which the optimal parameters were selected in each step. The performance of computer classification was evaluated using manual classification results as the reference. Ninety-seven ultrasonograms of contrast-enhanced rectal tumors were collected as validation set from 2018.1 to 2018.6. Results: The optimal gray level was set at 32. Principal component analysis (PCA) was the first choice for dimensionality reduction. The best classifier was support vector machines (SVM). The accuracy of computer classification was 87.80% (439/500). The accuracy of computer classification in the validation cohort was 60.82%. The area under the curve (AUC) of class 1, 2, and 3 were 0.76, 0.41, and 0.48, respectively. Conclusions: Results showed that the computer methods are competent for classifying inhomogeneity of contrast-enhanced rectal cancers inside ultrasonograms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.